We are a flagbearer for all Norwegian life sciences firms moving from development to commercialisation and a prime example of what the future could look like…
In Conversation
On a country by country basis, Norway has had the highest proportion of all COVID-19 patients enrolled in clinical trials
The environment is shifting at a more rapid speed than ever before. Past paradigms are obsolete
At MVC we have chosen a tried and tested technology platform as novel vaccine technologies face novel challenges
Up until COVID-19, Anaesthesia was incredibly underrepresented and undervalued as a therapeutic class. However, the pandemic has opened the door for anaesthesia because three agents are…
While it is true you can make great contributions in academia, I think you can make an even bigger contribution in industry because you are closer…
I see Merck’s Global Business Innovation (GBI) unit as the spider in a dense, extensive map of internal stakeholders
US physicians have learned that, out of necessity, they have to triage patients through digital tools like teleconferencing and Zoom, which has enabled them to become…
2020 has been very challenging for all of us. However, it has also been a year of reflection on what I am doing personally and what…
I was told when I came that Switzerland is a safe haven with easy access. What I experienced was something entirely different
In general, through the global COVID response, we’ve seen the walls between companies and across sectors come down as the industry thinks about tackling this public…
There are challenges and opportunities in every situation and, while there is no doubt that COVID-19 is challenging for all of us, it also creates a…
